These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 25261893)
21. Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India. Ihsan R; Chattopadhyay I; Phukan R; Mishra AK; Purkayastha J; Sharma J; Zomawia E; Verma Y; Mahanta J; Saxena S; Kapur S J Gastroenterol Hepatol; 2010 Aug; 25(8):1456-62. PubMed ID: 20659238 [TBL] [Abstract][Full Text] [Related]
22. EPHX1 gene polymorphisms and individual susceptibility to lung cancer. Voho A; Metsola K; Anttila S; Impivaara O; Järvisalo J; Vainio H; Husgafvel-Pursiainen K; Hirvonen A Cancer Lett; 2006 Jun; 237(1):102-8. PubMed ID: 16005144 [TBL] [Abstract][Full Text] [Related]
23. Impact of epoxide hydrolase 1 polymorphisms on lung cancer susceptibility in Asian populations. Yu W; Lin Z; Qu B Cell Biochem Biophys; 2015 Mar; 71(2):813-20. PubMed ID: 25312477 [TBL] [Abstract][Full Text] [Related]
25. EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians. Dura P; Bregitha CV; Te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH Oncol Rep; 2012 Jun; 27(6):1710-6. PubMed ID: 22447130 [TBL] [Abstract][Full Text] [Related]
26. Microsomal epoxide hydrolase gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in the Tunisian population. Lakhdar R; Denden S; Knani J; Leban N; Daimi H; Hassine M; Lefranc G; Chibani JB; Khelil AH Genet Test Mol Biomarkers; 2010 Dec; 14(6):857-63. PubMed ID: 20932192 [TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and the risk of breast carcinoma. Zhong JH; Li LQ; Mo XS; Gong WF; Ma L; Chen J; You XM Genet Mol Res; 2015 Apr; 14(2):4133-41. PubMed ID: 25966185 [TBL] [Abstract][Full Text] [Related]
28. Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer. Wang S; Zhu J; Zhang R; Wang S; Gu Z Tumour Biol; 2013 Apr; 34(2):1045-52. PubMed ID: 23378225 [TBL] [Abstract][Full Text] [Related]
29. Combined analysis of EPHX1, GSTP1, GSTM1 and GSTT1 gene polymorphisms in relation to chronic obstructive pulmonary disease risk and lung function impairment. Lakhdar R; Denden S; Knani J; Leban N; Daimi H; Hassine M; Lefranc G; Chibani JB; Khelil AH Dis Markers; 2011; 30(5):253-63. PubMed ID: 21734345 [TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma. Zhong JH; Xiang BD; Ma L; You XM; Li LQ; Xie GS PLoS One; 2013; 8(2):e57064. PubMed ID: 23451147 [TBL] [Abstract][Full Text] [Related]
31. EPHX1 rs1051740 T>C (Tyr113His) is strongly associated with acute myeloid leukemia and KMT2A rearrangements in early age. Brisson GD; de Almeida Lopes B; Andrade FG; Dos Santos Bueno FV; Sardou-Cezar I; de Aguiar Gonçalves BA; Terra-Granado E; Paraguassú-Braga FH; Pombo-de-Oliveira MS Arch Toxicol; 2018 Jun; 92(6):2001-2012. PubMed ID: 29605894 [TBL] [Abstract][Full Text] [Related]
32. [EPHX1 Tyr113His polymorphism contributes to hepatocellular carcinoma risk: evidfnce from a meta-analysis]. Wang D; Zhai JX; Zhang LM; Liu DW; Liu XH Mol Biol (Mosk); 2015; 49(2):351-61. PubMed ID: 26065263 [TBL] [Abstract][Full Text] [Related]
33. Association of EPHX1 polymorphisms with plasma concentration of carbamazepine in epileptic patients: Systematic review and meta-analysis. Hu T; Zeng X; Tian T; Liu J J Clin Neurosci; 2021 Sep; 91():159-171. PubMed ID: 34373022 [TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis. Erkisi Z; Yaylim-Eraltan I; Turna A; Görmüs U; Camlica H; Isbir T Tumori; 2010; 96(5):756-63. PubMed ID: 21302624 [TBL] [Abstract][Full Text] [Related]
35. Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study. Nisa H; Budhathoki S; Morita M; Toyomura K; Nagano J; Ohnaka K; Kono S; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R Mol Carcinog; 2013 Aug; 52(8):619-26. PubMed ID: 22415791 [TBL] [Abstract][Full Text] [Related]
36. EPHX1 rs2234922 polymorphism and lung cancer susceptibility in Asian populations: a meta-analysis. Xu X; Hua H; Fan B; Sun Q; Guo X; Zhang J J Thorac Dis; 2015 Jul; 7(7):1125-9. PubMed ID: 26380727 [TBL] [Abstract][Full Text] [Related]
37. EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis. Liu H; Li HY; Chen HJ; Huang YJ; Zhang S; Wang J Tumour Biol; 2013 Feb; 34(1):155-63. PubMed ID: 23055191 [TBL] [Abstract][Full Text] [Related]
38. Association between Jin Y Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2338-2342. PubMed ID: 31174441 [No Abstract] [Full Text] [Related]
39. EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Kiyohara C; Yoshimasu K; Takayama K; Nakanishi Y Epidemiology; 2006 Jan; 17(1):89-99. PubMed ID: 16357600 [TBL] [Abstract][Full Text] [Related]
40. Yang Q; Huang W; Yin D; Zhang L; Gao Y; Tong J; Li Z Front Genet; 2023; 14():1128985. PubMed ID: 37284064 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]